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Abstract
 . 5 6 9Growth hormone GH effects on fatty acid composition and on D -, D -, D -desaturase and palmitic acid elongation
activities were studied in male rat hepatic microsomes. Sham-operated and hypophysectomized animals were injected with
two different dosages of GH, mimicking either the male or female GH secretion pattern. Half the hypophysectomized
animals received thyroxine and cortisol in concentrations chosen to compensate for the lack of thyroid hormones and
glucocorticoids. GH, administered to sham-operated or to cortisolrthyroxine-treated hypophysectomized rats resulted in an
increase in stearic and arachidonic acid proportions, while palmitic acid percentage was decreased. Total monounsaturated
fatty acids were dramatically reduced by this treatment. D5-Desaturase and palmitic acid elongation activities were increased
by GH treatment, while D9-desaturase activity was decreased. These GH effects on desaturation and elongation activities
could explain the modifications in microsomal fatty acid composition. Hypophysectomy markedly altered the fatty acid
composition by reducing arachidonic and stearic acid proportions and increasing the linoleic acid proportion, while D9-,
D5-desaturase and palmitic acid elongation activities were decreased. Restoration of most of the fatty acid proportions to
control values was realized in hypophysectomized animals with a cortisolrthyroxine replacement administered alone or
together with the low dosage of GH mimicking the male secretion pattern. High GH dosage produces essentially a
‘feminization’ process of the fatty acid composition of the hepatic microsomal membrane in male rats when compared to
that of females. q 1997 Elsevier Science B.V.
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1. Introduction
Microsomal membrane structure and functions
seem to depend at least partly on its fatty acid
composition, which is mainly regulated by dietary
w xand hormonal factors 1–3 . This composition de-
pends on dietary triacylglycerol supply, de novo syn-
thesis of palmitic acid by fatty acid synthase and
successive chain desaturation andror elongation steps
w xof dietary essential and non-essential fatty acids 4 .
These enzymatic steps are involved in the biosynthe-
 .sis of the saturated SFAs , monounsaturated
 .  .MUFAs and polyunsaturated fatty acids PUFAs .
The rate-limiting steps of the desaturation reactions
were reported to be the terminal enzymes, i.e. the
 . w xdesaturases EC 1.14.99.y 5,6 . Various desat-
urases introduce a double bond at the D9-, D6- or
D5-position in the fatty acid chain. The effect of
nutritional dietary fat and particularly essential fatty
.acids, dietary proteins or cholesterol , environmental
 . temperature , genetic and hormonal factors espe-
cially thyroid hormones, glucocorticoids, insulin and
.glucagon on desaturation activities has been well
 w x.studied for reviews, see 1,3,4,7 . However, among
the various hormonal factors, the effect of growth
 .hormone GH on these activities and on the fatty
acid composition of microsomal membrane has been
poorly investigated.
Besides its effects on general body growth, protein
and carbohydrate metabolism, GH was reported to
have important effects on lipid metabolism. This
includes an increase in lipolysis and a stimulation of
w xthe production of ketone bodies in liver 8,9 . More-
over, GH was shown to decrease various lipogenic
enzyme activities in vitro: malic enzyme EC
.1.1.1.40 , fatty acid synthase complex, ATP-citrate
 .lyase EC 4.1.3.8 and glycerol-3-phosphate dehydro-
 .genase EC 1.1.99.5 , while glucose-6-phosphate de-
 .hydrogenase EC 1.1.1.49 was reported to be in-
w xcreased by this hormone 10 . In addition, GH was
reported to be particularly efficient in restoring fatty
acid composition of mitochondrial membrane to nor-
w xmal levels after hypophysectomy in rats 11 . GH was
also reported to ‘feminize’ fatty acid composition of
total liver phosphatidylcholine in hypophysectomized
w xfemale rats 12 . Yet, in microsomal membranes, it
has been only suggested that a large concentration of
GH increased membrane unsaturation and fatty acyl
w xchain length 13 . Some authors have shown that
some differences existed in the fatty acid composition
of microsomal membrane between male and female
w xrats 14 . These sex differences seem to be due to
modifications in the various desaturase activities. As
the sex-dependent activity of some hepatic enzymes
for example some cytochrome P-450 isoenzymes
.and some glutathione-S-transferase isoforms has been
shown to be regulated by the secretion pattern of GH
w x15–17 , which is different between male and female
rats, it is of interest to determine whether this hor-
mone could also account for the sex differences that
exist in the fatty acid composition of the hepatic
microsomal membrane.
In order to estimate the effect of GH treatment on
fatty acid composition of total phospholipids and on
D9-, D6-, D5-desaturation and palmitic acid elongation
activities, sham-operated and hypophysectomized
male rats were treated with two different concentra-
tions of GH. The low dosage was chosen to mimic
the male secretion pattern in hypophysectomized ani-
mals and the high dosage to mimic the female one in
male rats, while female rats were used as controls.
The conditions of restoration of the fatty acid compo-
sition, desaturation and elongation activities after hy-
pophysectomy were examined using the same con-
centrations of GH with or without coadministration
of physiological doses of thyroxine and glucocorti-
coid. Consequently, by using a factorial arrangement
of physiological treatments of animals, we were able
to quantify the deep sex-dependent implication of GH
in the hepatic microsomal membrane fatty acid com-
position.
2. Materials and methods
2.1. Animals
Male Sprague–Dawley rats, hypophysectomized or
sham-operated at 6 weeks of age, and female rats
 .were purchased from Iffa-Credo L’Arbresle, France .
Animals were weighed every day from their arrival in
the laboratory. They were individually housed under
 .conditions of controlled temperature 20–238C and
 .photoperiod 14:10 h lightrdark and were main-
tained ad libitum on a standard diet containing 64.8%
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carbohydrates, 6% lipids groundnut oilrrapeseed oil
 ..3:2 , 22.2% proteins, vitamins and minerals. The
fatty acid relative percentages of this diet were 12.9
SFA, 62.0 MUFA, 21.5 linoleic acid and 3.6 linolenic
acid. After allowing them to recover for 2 weeks,
hypophysectomized and sham-operated animals were
randomly divided into 9 groups of 8. Age-matched
females were used as a supplementary group. The
effectiveness of hypophysectomy was verified by the
absence of weight gain over this period. The animals
 .were given at 12-h intervals a subcutaneous injec-
tion of recombinant human growth hormone GH1,
.0.25 IUrkg b.wt.; GH2, 2 IUrkg b.wt. twice daily
 . while GH controls GH0 received only vehicle 25
.mM sodium carbonate buffer, pH 9.5, 0.9% NaCl .
Recombinant human growth hormone was a generous
 .gift from Sanofi Recherches Labege, France . Half`
the hypophysectomized animals were injected daily
 .with subcutaneous cortisol 400 mgrkg b.wt. and
 .  . L-thyroxine T 50 mgrkg b.wt. Sigma, St-Quen-4
. w xtin Fallavier, France as described previously 15,18 .
This T concentration was found to render hypophy-4
w xsectomized rats euthyroid 18 . The remaining ani-
 .mals received only vehicle 0.9% NaCl . This corti-
 .solrthyroxine treatment CT started 2 days prior to
GH treatment and lasted throughout the experimental
period. Weight gain during the treatment period
showed that hormone replacement was effective.
Control female rats only received the GH0 treatment.
After 16 days of treatment, animals were sacrificed
between 09.00 and 11.00 h to avoid any circadian
variation; blood was collected and the liver was
immediately perfused with Ringer solution via the
portal vein, excised, weighed and placed in liquid
nitrogen before storage at y808C. For microsomal
preparations, livers were minced and homogenized at
48C in 0.1 M sodium phosphate, pH 7.4. Ho-
mogenates were centrifuged sequentially at 11 000 g
 .  .15 min and 105 000 g 60 min at 48C on a
Centrikon T-1045 ultracentrifuge Kontron Instru-
.ments, St-Quentin-en-Yvelines, France in order to
prepare the microsomal pellets. Microsomal mem-
branes were resuspended in the homogenization buffer
containing 20% glycerol and were stored at y808C
until use. The amount of microsomal protein was
w xdetermined by the method of Lowry 19 using bovine
 .albumin Sigma as the standard. By using an im-
 . munoradiometric assay monoclonal antibodies hGH
.‘coatria’, bioMerieux, Marcy-l’Etoile, France , plas-´
mas from GH2-treated animals sham-operated and
.hypophysectomized were checked for the presence
of a significant amount of recombinant human growth
hormone at least 12 h after the last injection, which
determined a continuous GH exposure in these ani-
mals.
2.2. Lipid extraction and fatty acid analysis
Total lipids were extracted according to the method
w xof Bligh and Dyer 20 from liver microsomes in the
presence of 0.02% 2,6-di-tert-butyl-4-methyl-phenol
 .  .BHT Aldrich, St-Quentin Fallavier, France as an
antioxidant. Quantitative estimation of phospholipids
was performed by determination of inorganic phos-
w xphorus using the Bartlett procedure 21 . Cholesterol
was assessed from the total lipid fraction by an
enzymatic colorimetric test Cholesterol CHOD-PAP
method from Boehringer Mannheim, Mannheim,
.Germany . Neutral lipids and phospholipids were
separated on Supelclean LC-Si SPE silica cartridges
 .Supelco, St-Germain-en-Laye, France by successive
elutions with chloroform and methanol as described
w xpreviously 22 . The fatty acid composition of total
phospholipids was determined after transmethylation
 . in presence of BF 10% in methanol Fluka, St-3
.Quentin Fallavier, France for 20 min at 908C, fol-
lowed by an extraction of the methyl esters with
hexane. The fatty acid methyl esters were then ana-
lyzed by capillary gas–liquid chromatography on a
Chrompak model 438A apparatus Chrompak, Les
.Ulis, France , equipped with a Chrompak CP Wax 58
 .CB 50 m=0.32 mm i.d. 0.2 mm film thickness .
Peak areas were measured using a Hewlett-Packard
model 3390A integrator Hewlett-Packard, Les Ulis,
.France . Identification of peaks was assessed by com-
parison with the analysis of a reference fatty acid
 .mixture Nu-Chek-Prep Inc., Elysian, MN, USA and
confirmed by gas chromatography–mass spectrome-
try using a Delsi-Nermag GC apparatus coupled with
a Nermag R10-10T mass spectrometer Argenteuil,
.France .
2.3. Enzymatic assays
Unlabeled fatty acids, coenzymes and biochemi-
w 14 xcals were purchased from Sigma. 1- C Linoleic
( )F. Gueraud, A. ParisrBiochimica et Biophysica Acta 1329 1997 97–110´100
 . w 14 x1.48–2.22 GBqrmmol , 1- C eicosa-8,11,14-trien-
 . w 14 xoic 1.48–2.22 GBqrmmol and 1- C palmitic
 .1.48–2.22 GBqrmmol acids were provided by
 .DuPont NEN Les Ulis, France . Each substrate was
diluted into ethanol with the corresponding unlabeled
fatty acid to obtain a specific activity of 130
kBqrmmol. Final ethanol concentration in the assay
was 2%. The desaturation assays were carried out as
w xdescribed by Leikin and Brenner 23 with slight
modifications. D9-, D6- and D5-desaturase activities
were determined for each liver microsomal prepara-
w 14 xtion by measuring the conversion of 1- C palmitic
w 14 x w 14 xacid, 1- C linoleic acid and 1- C eicosatrienoic
acid to the corresponding unsaturated acids at 378C
for 30 min in the presence of 1.3, 3 and 2 mg of
microsomal proteins, respectively. The substrate con-
centration was 35 mM. The incubation medium con-
tained, in a total volume of 1 ml: 72 mM phosphate
 .buffer pH 7.4 , 5 mM MgCl , 2.5 mM ATP, 1 mM2
NADH, 0.33 mM niacinamide and 0.2 mM CoA.
The palmitic acid elongation assay was adapted
w xfrom the method described by Mimouni et al. 24 for
the elongation of arachidonic and eicosapentaenoic
acids, with slight modifications. The palmitic acid
elongation rate was determined in liver microsomes
w 14 xby measuring the conversion of 1- C palmitic acid
w 14 xto 1- C stearic acid at 378C for 20 min in the
presence of 1.3 mg of microsomal proteins. The
substrate concentration was 35 mM and the incuba-
tion medium contained in a total volume of 1 ml: 72
 .mM phosphate buffer pH 7.4 , 5 mM MgCl , 2.52
mM ATP, 1 mM NADH, 1 mM NADPH, 3 mM
glutathione and 0.1 mM malonyl-CoA. The incuba-
tions for elongation were carried out in anaerobic
 .conditions under nitrogen in order to inhibit desatu-
w xration 25 .
Under these conditions, the desaturation and elon-
gation rates were found to be linear with respect to
incubation time and microsomal protein amount. The
reaction was stopped by adding 1 ml of 10% ethano-
lic KOH. Lipids were saponified by heating for 45
min at 808C. Following acidification with 0.5 ml of 6
N-HCl, the fatty acids were extracted with hexane
 .containing 0.02% wrv BHT. Each radiolabeled
fatty acid and its corresponding desaturation or elon-
gation product were analyzed separately by HPLC
with a Philips model PU4100 apparatus Argenteuil,
.France equipped with an on-line radioisotope detec-
tor Radiomatic Flo-Onerbeta model A515 Packard,
. Meriden, CT, USA and a Hypersil C column 1508
=4.6 mm i.d., 3 mm particle size from Interchim
 . w 14 x wMontluc¸on, France . 1- C Linoleic acid, 1-
14 xC eicosatrienoic acid and their corresponding desat-
uration products were separated isocratically with
acetonitrilermethanolr25 mM ammonium acetate
 .buffer pH 3.4 57.5:17.5:25, vrvrv at a flow rate of
w 14 x1 mlrmin. 1- C Palmitic acid and its desaturation
and elongation products were separated isocratically
with acetonitrilermethanolr25 mM ammonium ac-
 .etate buffer pH 3.4 62.5:22.5:15, vrvrv at the
same flow rate. Peaks corresponding to elongation
and desaturation products were identified, after
methyl-coumarin derivatization according to the
w xmethod of Jungling and Kammermeier 26 by com-¨
parison of their retention time with those of authentic
fluorescent standards. Conversion percentage in con-
trols performed without cosubstrate coenzyme A or
.malonyl-CoA , reflecting non-specific conversion,
was removed from the experimental values.
2.4. Statistical analysis
All results are presented as means with their stan-
 .dard deviation S.D. . Fatty acid composition data,
expressed as percentage, were transformed into arc-
 .sine 6x to correct for unequal variances. The effect
of hormonal treatments on fatty acid composition and
on desaturase and palmitic acid elongation activities
 .was analyzed by analysis of variance ANOVA us-
w xing the GLM procedure of SAS 27 . When using
two-factor variance analyses on CT-untreated animals
 .additive model, Hypophysectomy)GH or on hy-
 .pophysectomized rats additive model, GH)CT ,
first-order interactions between treatments most often
proved to be highly significant. Thus, the effect of
each treatment was also tested in the following re-
duced groups of animals: GH treatment in sham-op-
erated rats, hypophysectomized CT-untreated rats and
hypophysectomized CT-treated rats, separately; and
hypophysectomy in GH-untreated rats. Inside these
different groups, the statistical analysis of differences
between the means was performed using Student–
Newman–Keuls test. In order to further examine the
conditions of hormonal restoration of control values
after hypophysectomy, comparisons of means be-
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tween the 9 groups of animals were performed using
Student–Newman–Keuls test. In order to simultane-
ously assess the relative effects of the various physio-
logical factors on the various fatty acid proportions, a
 .multivariate variance analysis MANOVA was car-
ried out, completed by a factorial discriminant analy-
sis of the different groups of animals. This latter
descriptive statistical methodology was first intended
to give a hierarchy between the effect of hypophysec-
tomy and the cortisolrthyroxine restitution treatment
on the one hand and the GH treatment on the other,
and second, to test a posteriori, simultaneously for
the different fatty acid proportions, the hormonal
conditions chosen to restitute control hormonal situa-
tion from hypophysectomized animals and the
‘feminization’ process with GH2 treatment. The dis-
criminant analysis is equivalent to a principal compo-
nent analysis performed on the barycenters of the
different groups of animals which maximizes the
distances between these groups and minimizes the
distances between individuals inside these groups
w x28–30 . This analysis can reduce the total variance
 .or information given by initial variables to some
 .principal components or discriminant axes which
summarize this information. This analysis gives an
explanation of these linear discriminants by the corre-
Table 1
 .Sex-differences and effects of GH treatment, hypophysectomy and hormonal replacements on total phospholipid PL and cholesterol
 .  .  .CL levels, phospholipidrprotein PLrP and cholesterolrtotal phospholipid CLrPL ratios in microsomes from male rats
Sham-operated Hypophysectomized
Male rats Female rats CTy CTq
 .PL mgrg of liver
a c dGH0 3.400"0.58 3.060"0.40 2.100"0.43 3.000"0.87
GH1 2.890"0.80 2.770"0.93 2.400"0.67
GH2 2.940"0.78 2.290"0.69 2.880"0.72
GH effect n.s. n.s. n.s.
PLrP
GH0 0.220"0.06 0.200"0.03 0.170"0.03 0.180"0.04
GH1 0.190"0.06 0.180"0.06 0.160"0.03
GH2 0.190"0.03 0.160"0.02 0.170"0.04
GH effect n.s. n.s. n.s.
 .CL mgrg of liver
GH0 0.230"0.07 0.230"0.04 0.160"0.05 0.190"0.04
GH1 0.190"0.04 0.180"0.07 0.170"0.06
GH2 0.190"0.05 0.180"0.06 0.200"0.06
GH effect n.s. n.s. n.s.
CLrPL
bGH0 0.066"0.006 0.082"0.010 0.078"0.019 0.065"0.015
GH1 0.068"0.011 0.071"0.037 0.073"0.012
GH2 0.063"0.007 0.080"0.021 0.074"0.022
GH effect n.s. n.s. n.s.
The results are the mean of eight individual determinations"S.D. The measurements were done as described in Section 2. n.s.,
non-significant effect of GH treatment in the following groups of animals: sham-operated rats, hypophysectomized CT-untreated rats or
hypophysectomized CT-treated rats. CT, cortisolrthyroxine treatment; GH, growth hormone treatment; GH0, no GH treatment; GH1,
low-dosage treatment; GH2, high-dosage treatment.
a Significant difference between sexes at P-0.05.
b Significant difference between sexes at P-0.001.
c Italic value shows a significant effect of hypophysectomy at P-0.05.
d Bold values show the necessary combination of hormonal treatments of hypophysectomized animals for a restitution of the control
 .values statistically not different from sham-operated untreated animals with Student–Newman–Keuls test.
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lations they have with the initial variables. The facto-
rial discriminant analysis was performed using the
w xDISCRIM procedure of SAS 27 .
3. Results
3.1. Sex differences and effects of GH treatment,
hypophysectomy and hormone replacements on phos-
( ) ( )pholipid PL and cholesterol CL concentrations
In sham-operated rats, PL and CL concentrations
 .expressed as mg per g of liver , and PLrprotein
 .PLrP and CLrPL ratios were not affected by GH
 .Table 1 . Hypophysectomy induced a significant
 .reduction by 38% of PL concentration, though PLrP
and CLrPL were not significantly altered. This mod-
ification of PL concentration due to hypophysectomy
was reversed by all hormonal replacements. In fe-
males, PL concentration was 10% lower than in
males and consequently, the CLrPL ratio was 24%
higher.
3.2. Sex differences and effects of GH treatment on
fatty acid composition of hepatic microsomal total
phospholipids of male rats
In sham-operated animals, GH induced a signifi-
cant increase in 18:0 by 19 and 35% with GH1 and
.GH2 treatments, respectively and an almost correla-
tive significant decrease in 16:0 by 15 and 30% with
.  .GH1 and GH2 treatments, respectively Table 2 .
Consequently, total SFAs were only slightly, but
significantly, increased. Total MUFAs were very sig-
nificantly decreased by GH by 12 and 20% with
.GH1 and GH2 treatments, respectively due to an
Table 2
Sex differences and effects of GH treatment on fatty acid composition of total phospholipids of sham-operated male animal liver
microsomes
Fatty acids Sham-operated male rats Female rats
GH0 GH1 GH2 GH effect GH0 sex effect
a a b14:0 0.28"0.06 0.25"0.05 0.22"0.02 P-0.05 0.17"0.02 P-0.001
a b c16:0 20.59"0.86 17.58"1.99 14.48"0.39 P-0.001 13.01"0.51 P-0.001
a b c16:1ny7 1.77"0.35 1.33"0.44 0.67"0.25 P-0.001 0.61"0.21 P-0.001
a b c18:0 21.06"1.19 25.14"1.90 28.36"1.22 P-0.001 33.66"1.23 P-0.001
18:1ny9 6.42"0.91 6.02"0.71 6.05"0.75 n.s. 4.92"0.46 P-0.001
a a,b b18:1ny7 4.10"0.48 3.40"0.35 2.94"0.57 P-0.001 1.32"0.15 P-0.001
18:2ny6 12.28"1.40 11.36"1.27 11.68"0.94 n.s. 10.56"0.93 P-0.01
18:3ny3 0.09"0.04 0.12"0.04 0.11"0.05 n.s. 0.08"0.03 n.s.
a a,b b20:3ny6 1.33"0.17 1.23"0.17 0.98"0.15 P-0.01 1.22"0.20 n.s.
a a,b b20:4ny6 21.99"0.78 22.69"1.57 24.20"1.23 P-0.01 23.54"0.58 P-0.001
20:5ny3 0.56"0.08 0.68"0.07 0.59"0.06 n.s. 0.77"0.21 P-0.01
22:4ny6 0.39"0.03 0.38"0.05 0.32"0.02 n.s. 0.41"0.08 n.s.
22:5ny6 0.58"0.11 0.74"0.23 0.48"0.06 n.s. 0.62"0.25 n.s.
a a b22:5ny3 0.89"0.12 0.76"0.21 0.59"0.08 P-0.01 0.75"0.10 P-0.05
22:6ny3 6.72"0.88 7.04"0.82 7.21"0.72 n.s. 8.32"0.85 P-0.001
a b bSFA 42.03"0.67 43.06"0.62 42.77"0.82 P-0.05 45.98"0.81 P-0.001
a a,b bMUFA 12.68"0.76 11.12"0.92 10.16"1.18 P-0.001 7.31"0.73 P-0.001
a a bPUFA 45.30"0.78 45.83"1.41 47.07"0.89 P-0.01 46.38"0.19 P-0.001
ny3 8.26"0.85 8.55"0.83 8.56"0.82 n.s. 9.87"0.50 P-0.001
ny6 36.48"0.87 36.61"1.87 38.31"0.93 n.s. 36.16"0.66 n.s.
20:4r18:2 1.79"0.28 2.02"0.26 2.09"0.22 P-0.08 2.36"0.21 P-0.001
DBI 157.4 "8.4 162.4 "4.9 165.3 "6.0 P-0.08 162.1 "2.7 n.s.
Data are expressed as mean of eight individual determinations"S.D. Analysis of the samples was done as described in Section 2. n.s.,
non-significant effect of GH treatment or no sex difference. GH, growth hormone treatment; GH0, no GH treatment; GH1, low-dosage
treatment; GH2, high-dosage treatment.
a – c  .Significant differences between GH treatments within each group at P-0.05 Student–Newman–Keuls test .
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important reduction in the 16:1ny7 and 18:1ny7
proportions, while 18:1ny9 was unchanged. Total
PUFAs were significantly increased by 4% by GH2
treatment, primarily due to an increase in 20:4ny6
 .by 10% , while 18:2ny6 and 22:6ny3 remained
unchanged and 20:3ny6 was decreased by 26%
with GH2 treatment. In these GH2-treated animals,
 .the double bond index DBI and the 20:4ny
6r18:2ny6 ratio were only slightly increased Ps
.0.07 for both variables as compared with sham-oper-
ated untreated rats. Besides, total amounts of ny3
and ny6 fatty acids were not significantly altered
by this treatment. In all cases, GH effect is dose-de-
 .pendent Table 2 .
As compared to sham-operated untreated males,
females showed very significant differences in the
 .proportion of the major fatty acids Table 2 . In fact,
18:0 was dramatically increased by 64% in females
and 16:0 was concomitantly decreased by 37%. Total
SFAs were increased by 9%. Total MUFAs were
decreased by 42% in females due to an important
reduction in all the MUFA proportions 16:1ny7,
18:1ny9 and 18:1ny7 being decreased by 65, 23
.and 68%, respectively . Total PUFAs were slightly,
but significantly, increased by 2% in females as
compared to males, primarily due to a 7% increase in
20:4ny6 and to a 24% increase in 22:6ny3, while
18:2ny6 was decreased by 14%. Consequently, the
 .total amount of ny3 but not ny6 fatty acids was
enhanced by 19% in females as compared to males.
The 20:4ny6r18:2ny6 ratio was increased by
32% in females, but the DBI showed no significant
sex difference.
3.3. Effects of hypophysectomy and hormone replace-
ments on fatty acid composition of hepatic microso-
mal total phospholipids of male rats
Hypophysectomy of male rats had the opposite
effect to that observed after GH treatment. It signifi-
cantly decreased the proportion of total SFAs by
.  .5% , especially 18:0 by 11% , while the 16:0 pro-
 .portion remained unchanged Table 3 . Total MUFAs
were increased by 19% in hypophysectomized rats,
with an important increase of the 18:1ny9 propor-
 .tion by 62% while 16:1ny7 and 18:1ny7 were
 .decreased by 47 and 41%, respectively . Hypophy-
sectomy significantly decreased both 20:4ny6 and
22:6ny3 by 35%, and increased the 18:2ny6,
18:3ny3 and 20:3ny6 proportions by 63, 155 and
92%, respectively. The 22:4ny6, 22:5ny6 and
22:5ny3 proportions were also significantly reduced
 .Table 3 . Nevertheless, total PUFAs were un-
changed. Hypophysectomy decreased dramatically the
 .20:4ny6r18:2ny6 ratio by 60% and the DBI by
24%. The ny3 PUFAs were also significantly re-
 .duced by 27% in hypophysectomized animals.
GH treatment of hypophysectomized animals
tended to reverse the effects of hypophysectomy for
most of the different fatty acid relative concentrations
in a dosage-dependent manner and GH2 was suffi-
cient to restore entirely the amounts of 18:0, 20:3ny
6, 20:5ny3 and 22:6ny3, total SFAs, total MU-
 .FAs but not each MUFA taken separately and the
ny3 fatty acid family. GH treatment alone was not
sufficient to completely restore either the 18:2ny6
or the 20:4ny6 proportions, nor the 20:4ny
6r18:2ny6 ratio and the DBI to the level of sham-
operated rats.
Complete restoration of the 14:0, 18:2ny6, 18:3n
y3 and 20:4ny6 proportions and of the 20:4ny
6r18:2ny6 ratio to the level of sham-operated rats
was achieved in hypophysectomized rats with CT
treatment administered alone. However, concomitant
treatment of hypophysectomized rats with CT and
GH1 was necessary for a complete restoration of
22:4ny6 proportion. For 16:1ny7 and 18:1ny7,
the restoration was far from complete, regardless of
the treatment used. 18:1ny9 proportion and DBI
were restored with concomitant CT and GH2 treat-
ments in hypophysectomized rats.
3.4. Sex differences and effects of GH treatment,
hypophysectomy and hormonal replacements on D9-,
D5-, D6-desaturase and palmitic acid elongation ac-
ti˝ities
In sham-operated animals, GH treatment increased
palmitic acid elongation activity by 40% with GH2
. 5 treatment and D -desaturase activity by 52% with
.  .GH2 treatment in a dose-dependent manner Fig. 1 .
In contrast, D9-desaturase activity was significantly
 . 6depressed by 41% with GH2 treatment only. D -De-
saturase activity was not significantly changed, what-
ever the concentration of GH used.
As compared to untreated males, females showed a
(
)
F.G
ueraud,A.Parisr
Biochim
ica
etBiophysica
Acta
1329
1997
97
–110
´
104
Table 3
Effects of hypophysectomy and hormonal replacements on fatty acid composition of total phospholipids of liver microsomes in male rats
Fatty acids Controls Hypophysectomized
CTy CTy CTq
GH0 GH0 GH1 GH2 GH effect GH0 GH1 GH2 GH effect
d e14:0 0.28"0.06 0.41"0.09 0.47" 0.22 0.44" 0.14 n.s. 0.28"0.04 0.24"0.09 0.25"0.03 n.s.
16:0 20.59"0.86 20.72"0.75 22.22" 1.05 20.43" 1.15 n.s. 20.04"0.80 18.47"1.68 15.50"1.97 n.s.
a b b16:1ny7 1.77"0.35 0.94"0.20 1.16" 0.53 0.98" 0.30 n.s. 0.81"0.14 0.49"0.22 0.35"0.06 P -0.001
a,b a b18:0 21.06"1.19 18.66 "1.44 17.68" 2.13 19.76" 0.90 P -0.05 23.89"0.73 24.70"1.77 25.74"2.51 n.s.
a a b a a b18:1ny9 6.42"0.91 10.42"0.57 9.79" 0.57 8.01" 0.69 P -0.001 8.75"1.01 8.52"0.81 7.19"0.66 P -0.05
a a,b b18:1ny7 4.10"0.48 2.42"0.23 2.86" 0.21 3.31" 0.73 P -0.01 2.67"0.22 2.61"0.33 2.43"0.27 n.s.
a a b18:2ny6 12.28"1.40 20.01"1.27 19.10" 1.07 15.61" 1.68 P -0.01 13.14"0.46 13.01"0.74 12.64"0.65 n.s.
18:3ny3 0.09"0.04 0.23"0.05 0.20" 0.04 0.17" 0.06 n.s. 0.08"0.02 0.11"0.04 0.09"0.02 n.s.
a a b a a b20:3ny6 1.33"0.17 2.55"0.34 2.35" 0.64 1.41" 0.20 P -0.001 1.34"0.12 1.04"0.17 0.66"0.10 P -0.001
a b c a a,b b20:4ny6 21.99"0.78 14.23"1.22 15.78" 1.89 19.39" 1.85 P -0.001 21.72"1.17 22.75"1.77 23.60"1.45 P -0.08
a b a,b a,b a a,b20:5ny3 0.56"0.08 0.83"0.26 0.56" 0.17 0.66" 0.11 P -0.05 0.37"0.04 0.41"0.04 0.26"0.09 P -0.05
22:4ny6 0.39"0.03 0.19 "0.03 0.24" 0.05 0.22" 0.03 n.s. 0.30"0.04 0.33"0.02 0.33"0.05 n.s.
22:5ny6 0.58"0.11 0.26 "0.13 0.26" 0.08 0.36" 0.17 n.s. 0.34"0.11 0.29"0.06 0.32"0.12 n.s.
22:5ny3 0.89"0.12 0.60 "0.13 0.65" 0.09 0.55" 0.14 n.s. 0.47"0.09 0.60"0.03 0.48"0.08 n.s.
a b c a a,b b22:6ny3 6.72"0.88 4.37 "0.67 5.44" 0.72 6.45" 0.74 P -0.001 4.72"0.38 5.27"0.34 5.78"0.52 P -0.001
SFA 42.03"0.67 40.04"0.98 40.29" 1.84 40.93" 1.80 n.s. 44.26"0.99 43.47"1.29 44.93"1.21 n.s.
a a b a a bMUFA 12.68"0.76 15.06 "1.56 14.47" 0.53 13.26" 1.29 P -0.05 12.58"0.88 12.17"1.03 10.52"0.86 P -0.01
PUFA 45.30"0.78 45.47"1.31 45.29" 1.75 45.81" 1.93 n.s. 43.15"1.62 44.77"1.92 44.96"1.47 n.s.
a a b a b bny3 8.26"0.85 6.04"0.91 6.80" 0.59 7.82" 0.80 P -0.001 5.62"0.44 6.38"0.39 6.61"0.50 P -0.001
ny6 36.48"0.87 37.80"1.62 37.84" 1.38 37.97" 1.34 n.s. 37.05"1.38 37.96"1.78 37.43"0.84 n.s.
a b c a a,b b20:4r18:2 1.79"0.28 0.71"0.07 0.88" 0.19 1.26" 0.22 P -0.001 1.65"0.08 1.76"0.19 1.87"0.15 P -0.05
a b c a a,b bDBI 157.40"8.4 119.40"4.4 132.60"13.0 145.10"10.1 P -0.001 140.60"5.6 148.00"6.5 150.20"5.4 P -0.01
Data are expressed as the mean of eight individual determinations"S.D. Analysis of the samples was done as described in Section 2: Materials and methods. CT, cortisol
and thyroxine treatment. CTy, CT-untreated animals. CTq, CT-treated animals. Controls are sham-operated untreated male rats. GH, growth hormone treatment; GH0,
no GH treatment; GH1, low-dosage treatment; GH2, high-dosage treatment. n.s., non-significant effect of GH treatment in the following groups of animals:
hypophysectomized CT-untreated rats or hypophysectomized CT-treated rats.
a – c  .Significant differences between GH treatments within each group at P -0.05 Student–Newman–Keuls test .
d Italic values show a significant effect of hypophysectomy at P -0.05.
e Bold values show the necessary combination of hormonal treatments of hypophysectomized animals for a restitution of the control values statistically not different from
.sham–operated untreated animals with Student–Newman–Keuls tests.
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9  .reduced D -desaturase activity by 21% . The other
activities tested were not significantly different be-
 .tween male and female rats Fig. 1 .
All the activities tested, except for D6-desaturase,
were significantly depressed by hypophysectomy: by
81, 43 and 38% for D9-, D5-desaturase and palmitic
 .acid elongation activities, respectively Fig. 1 .
In hypophysectomized rats, D5-desaturase activity
values of control animals were restored with GH2 or
CT treatment. The other activities altered after hy-
pophysectomy were not significantly modified by GH
treatment administered alone at any concentration.
The effect of hypophysectomy was completely re-
versed for D9-desaturase activities with CT treatment,
but CT and GH2 treatments administered together
were necessary to reverse the depressing effect of
hypophysectomy for palmitic acid elongation activity
 .Fig. 1 .
Fig. 1. Effect of GH treatment, sex, hypophysectomy and hormonal replacements on microsomal D9-, D5-, D6-desaturase and palmitic acid
elongation activities. Activities were measured as described in Section 2: Materials and methods. Values are the mean of eight individual
determinations"S.D. CT, cortisolrthyroxine treatment; GH, growth hormone treatment; GH0, no GH treatment; GH1, low-dosage
treatment; GH2, high-dosage treatment; hypox, hypophysectomized rats; sham-op, sham-operated rats; ?, male rats; Y, female rats.
Asterisks show a significant effect of GH in the following groups of animals: sham-operated male rats, hypophysectomized CT-untreated
rats and hypophysectomized CT-treated rats with ) P-0.05, )) P-0.01 and ))) P-0.001, respectively. a and b show significant
 .differences between GH treatments within each group at P-0.05 Student–Newman–Keuls test . a and b show a significant effect of
sex at P-0.05. A and B show a significant effect of hypophysectomy at P-0.05. Black bars represent the necessary combination of
hormonal treatments of hypophysectomized rats for a restoration of the control values statistically not different from sham-operated
.untreated rats with Student–Newman–Keuls tests.
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3.5. Relati˝e importance of the different treatments
used
MANOVA performed on the various fatty acid
 .proportions was highly significant P-0.0001 . The
pseudo-F-value associated with this multivariate
analysis was larger than any F-value associated with
the univariate analysis of fatty acids, which enabled
us to pursue a discriminant analysis on this set of
 .variables. The first factorial map Fig. 2 constructed
from the first and the second linear discriminants
accounted for 82.3% of the total variance or infor-
. mation first component, 67.0%; and second compo-
.nent, 15.3% . The third, fourth and fifth linear dis-
criminants represented 9.7, 3.7 and 2.4% of the total
variance, respectively. The third to fifth linear dis-
criminants were significant, but represented a low
amount of information. Besides, they were explained
by only minor fatty acids. For this reason and be-
cause they summarized an insufficient amount of
information, they were excluded from the discrimi-
nant analysis interpretation. The first principal com-
ponent was well explained by 20:4ny6 correlation:
.  .  .y96% , 18:2ny6 q95% , 14:0 q92% , 18:3ny
 .  .  .3 q86% , 20:3ny6 q86% , 18:0 y79% , 22:4n
 .  .y6 q70% and by 18:1ny9 q69% . The second
linear component was explained by 22:6n y 3
 .  .  .q64% , 20:5ny3 q50% , 18:1ny7 q48% ,
 .22:5ny3 q47% and to a lesser extent by 16:1ny
 .7 q34% . Analysis of the projection of individuals
on the first linear component gave a clear opposition
between the group of hypophysectomized animals on
the one hand, and the groups of sham-operated rats
and hypophysectomized CT-treated rats on the other.
Yet, there was no superimposition of the group of
hypophysectomized CT-treated animals on the group
of sham-operated animals when they were projected
on the second factorial axis. In order to give a
hierarchy between the effect of hypophysectomy, GH
and CT, Mahalanobis distances Euclidean distances
.corrected for correlations between initial variables
were calculated. Hypophysectomy appeared to have
the major influence on the perturbation of microso-
mal fatty acid composition. CT effect was very sig-
Fig. 2. Projection on the first factorial map built by the first two linear discriminant axes of the data of fatty acid compositions of
individuals characterized by their belonging to the different treatment groups. The first and the second linear discriminants explain 67.0
and 15.3% of the total variance, respectively. Black triangles and square represent the location of group means for male and female rat
groups, respectively. The female rat group is projected on the factorial map as a supplementary rat group. Sh, sham-operated rats; Hx,
 .  .hypophysectomized rats; Fe, female rats; 0, control rats for GH treatment GH0 ; 1, rats treated with the low GH dosage treatment GH1 ;
 .  .2, rats treated with the high GH dosage treatment GH2 ; q, rats treated with cortisolrthyroxine CT treatment; y, control rats for CT
treatment.
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nificant in hypophysectomized rats. In fact, for most
of the major fatty acids which explained the first
.linear component , CT treatment seemed to be suffi-
cient in getting hypophysectomized rats superim-
posed to sham-operated controls. Nevertheless, this
treatment was not sufficient to recover control values
for 18:1ny7, 22:6ny3 and 16:1ny7 explaining
.the second discriminant axis . GH1 and GH2 effects
appeared to be also highly significant on microsomal
fatty acid composition, the GH2 effect being more
important in hypohysectomized CT-untreated rat than
in hypophysectomized CT-treated or sham-operated
 .rats Fig. 2 .
The female animals, projected as a supplementary
group, tended to be superimposed on the GH2-treated
sham-operated animal group. Moreover, when the
attribution of the female individuals in the different
male groups was tested, all the females were at-
tributed to this sham-operated GH2-treated rat group.
This clearly summarizes a ‘feminization’ process of
the microsomal fatty acid pattern related to continu-
 .ous GH exposure GH2 treatment .
4. Discussion
4.1. GH-dependent ‘ feminization’ of microsomal fatty
acid composition
The fatty acid composition of microsomal phos-
pholipids in sham-operated young adult Sprague–
Dawley rats was comparable with that already de-
scribed for the same strain and the same age animals
w x31 . In the present study, physiological dosages of
GH were chosen in order to restore a male-like or a
female-like secretion pattern of GH in hypophysec-
w xtomized rats 32 . As such, the GH1 dosage chosen in
our experiments is commonly used to mimic, in
hypophysectomized rats, the pulsatile GH pattern pre-
w xsent in male rats 33 and the GH2 dosage, which is 8
times higher than that of GH1, was chosen in order to
determine, in male rats, a continuous GH exposure,
as is the case in females. This GH2 dosage was
sufficient to mimic female secretion profile in males,
as shown by a female-predominant steroid metabo-
 4 .lization activity D -3-oxosteroid 5a-reductase ob-
tained at the same time in GH2-treated animals un-
.published data . Our results show that, in sham-oper-
ated animals, GH decreased total MUFAs by 12 and
20% with GH1 and GH2 treatments, respectively.
Concomitantly, GH increased total PUFA amount
with an increase in the 20:4ny6 proportion, but not
in the 22:6ny3 one, while fatty acid chain length
was increased in SFAs. Yet, the DBI, which reflects
the membrane unsaturation state seemed to be in-
 .creased Ps0.07 by this treatment. These results
w xare in accordance with those of others authors 13 , in
 .which a larger dose of GH 10 IUrkg b.wt. signifi-
cantly increased the DBI, the 20:4ny6r18:2ny6
ratio and the 22:6ny3 proportion in the microsomal
membrane. In our study, the more limited influence
of GH on these latter parameters could be related to a
dosage-dependent effect of GH on fatty acid compo-
sition of microsomal membrane. In fact, with the
nearly physiological concentration of GH used, we
have noted a dose-related effect for some other pa-
rameters: MUFAs, 20:4ny6, 18:1ny7, 16:0 and
18:0.
These results, together with the superimposition of
the female group on the GH2-treated sham-operated
male rat group observed in the discriminant analysis
 .Fig. 2 , are in accordance with a ‘feminization’
process of the fatty acid composition of the microso-
mal membrane, since female rats show lower propor-
tions of 16:0, 18:2ny6 and MUFAs, higher propor-
tions of 18:0, 20:4ny6 and 22:6ny3 and a higher
20:4ny6r18:2ny6 ratio, as compared to male rats.
This ‘feminization’ process appears to be dose-de-
pendent in intact males. Such a dose-dependent
‘feminization’ process with GH was also reported by
w xothers 12 for the ‘feminization’ of fatty acid compo-
sition of liver total phosphatidylcholine in hypophy-
sectomized female rats submitted to GH infusion.
Modifications of desaturation andror elongation
rates could account for the effects of GH treatment
on the fatty acid composition of microsomal mem-
branes, since GH caused important changes in D9-,
D5-desaturase activities and in palmitic acid elonga-
tion rate. The increase in D5-desaturase activity in-
duced by GH could explain the enhanced 20:4ny6
proportion and the reduced 20:3ny6 one, this latter
fatty acid being provided by a desaturationrelonga-
tion step involving D6-desaturase which is not en-
hanced by GH treatment. The increase in palmitic
acid elongation activity could account for the in-
crease of the 18:0r16:0 ratio, although the decrease
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in 16:0 could also be partially explained by an effect
of GH treatment on fatty acid synthase activity,
which was reported to be decreased by GH in cul-
w x 9tured rat hepatocytes 10 . The decrease in D -de-
 .saturase activity measured with 16:0 as substrate
could explain the reduced microsomal 16:1ny7 pro-
portion, but surprisingly, the 18:1ny9 concentra-
tion, which should also depend on D9-desaturase
activity, is not modified by any GH treatment. D9-de-
saturase activity, which was significantly reduced in
females as compared to males, could explain the
reduced MUFA proportions. Surprisingly, the other
desaturation activities and the palmitic acid elonga-
tion activity presented no significant sex differences
that could have accounted for the sex differences
observed in major PUFAs and SFAs. Sex differences
in microsomal fatty acid composition have been re-
ported by others and were attributed to the effect of
w xtestosterone on the various desaturation activities 14 .
In fact, these authors showed that testosterone had
depressing effects on D5- and D6-desaturase activities
and an activating effect on D9-desaturase activity. For
some other hepatic activities, the testosterone effect
on some cytochrome P-450-mediated steroid hydrox-
ylation activities is known to be exerted via its direct
w xeffect on the GH secretion pattern 16,34 . This GH
secretion pattern shows, in male rats, few high-ampli-
tude secretion peaks and complete and prolonged
suppression of circulating GH levels during the trough
period after a GH surge, while in females, it shows
frequent low-amplitude secretion peaks that result in
w xpersistent GH circulating levels 15,32,35 . Adminis-
tration of exogenous GH may interfere, in males,
with testosterone regulation of GH secretion pattern
mainly via hypothalamic somatostatin release
w x32,34,36 by removing these periods of suppression
of GH circulating levels. In the same way, we can
suggest that the continuous stimulation of GH in
 .these animals GH2 treatment , which results in a
‘feminization’ of the fatty acid composition of the
microsomal membrane, parallels the modifications
observed in the hepatic steroid hydroxylation and
testosterone 5a-reductase patterns of these animals,
particularly by increasing the testosterone 5a-re-
ductase activity and lowering testosterone 2a- and
 .16a-hydroxylase activities unpublished data . Such
a ‘feminization’ of hepatic steroid metabolism in
male rat with a continuous GH infusion has been well
w xdocumented 34,36,37 . This may indicate that the
modulation of the D5-, D9-desaturase and palmitic
acid elongation activities is mediated by the secretion
pattern of GH, as it has been shown for CYPIIC12
 .responsible for the steroid 15b-hydroxylase activity
and CYPIIC11 responsible for the testosterone 2a-
. w xand 16a-hydroxylase activities 15,33 . In the same
way, in hypophysectomized animals whose lack of
thyroid hormones and glucocorticoids has been com-
pensated by CT treatment, the GH2 treatment, that
determined a continuous exposure to GH, tended to
‘feminize’ major SFA and PUFA proportions, when
compared to the effects induced by GH1 treatment
 .Table 3 and Fig. 2 . However, the complete assess-
ment of the ‘feminization’ of the D5-, D9-desaturase
and palmitic acid elongation activities depending on
GH pulsatility should be achieved by the study of the
conditions of ‘masculinization’ of hepatic microso-
mal fatty acid composition in hypophysectomized
female rats.
4.2. GH coregulation with other pituitary-dependent
factors of fatty acid composition and desaturaser
elongase acti˝ities
Hypophysectomy dramatically decreased the 20:4n
y6r18:2ny6 ratio and the relative proportion of
22:6ny3 in hepatic microsomal membrane. The
same effects were described by others in rat hepatic
w xmitochondrial membrane 11 . These modifications
are in agreement with the results obtained on D5-de-
saturase activity which is dramatically reduced by
.52% and may become rate-limiting for the biosyn-
thesis of 20:4ny6. This modification could also
account for the accumulation of 20:3ny6 increased
.by 92% in hypophysectomized rats. The deeply re-
duced D9-desaturase activity in these rats may explain
the decrease in 16:1ny7 proportion. Reduction of
 .18:0 by 11% following hypophysectomy is corre-
lated with the reduced palmitic acid elongation rate.
These modifications of the various microsomal desat-
urase activities due to hypophysectomy are consistent
with the previous findings of Clejan and Maddaiah
w x11 , but the effects observed in our study are more
pronounced. Interestingly, these authors showed that
microsomal total fatty acid elongation activity was
enhanced by hypophysectomy, while our results show
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a decrease in palmitic acid elongation rate. However,
it has been shown that there are at least two distinct
elongation systems: one for the saturated fatty acids
w xand another for the unsaturated ones 38 . Clejan and
w xMaddaiah 11 showed that bovine GH administration
 .1 IUrkg b.wt. was sufficient to reverse the effects
of hypophysectomy on fatty acid composition of
mitochondrial membrane and on desaturase activities
 9except for D -desaturase activity when it is not in-
. w xduced by sucrose 11 . Our results clearly show that
GH treatment reversed the effects of hypophysec-
tomy at least partly, while cortisol andror thyroxine
treatments were important for the recovery of the
fatty acid composition of the microsomal membrane
in hypophysectomized rats to the level of controls, as
shown by the superimposition of the CT-treated hy-
pophysectomized rat group on the sham-operated
control one when projected on the first linear discrim-
 .inant Fig. 2 . Moreover, CT treatment was a neces-
sary physiological condition for the expression of the
GH effect on D9-desaturase and palmitic acid elonga-
tion activities in hypophysectomized animals. The
observation that some MUFA proportions were not
restored after hypophysectomy to the control values
with CT and GH treatments could indicate that other
pituitary factors are of importance in the regulation of
microsomal membrane composition. Besides, D9-de-
saturation activity may not be the only mechanism
regulating the amount of MUFAs since this activity
was restored by CT treatment after hypophysectomy.
Thyroidectomy was shown to decrease dramatically
D9-, D5- and D6-desaturase activities, and conse-
quently, to modify the fatty acid composition of
w xmicrosomal membrane 39 . These effects, which are
comparable to those observed after hypophysectomy,
are reversed by thyroid hormone treatment and under-
line the importance of these hormones for the regula-
tion of desaturation activities. This effect of thyroid-
ectomy could be indirect by a great reduction of GH
secretion, as it was demonstrated that thyroidectomy
dramatically decreased GH secretion in rodents
w x40,41 . Nevertheless, our results clearly show that
thyroxine andror cortisol are also essential endocrine
conditions involved in fatty acid desaturation regula-
tion. The effect of hypophysectomy is the result of
the deprivation of several pituitary factors. Some of
 .these, as adrenocorticotropic hormone ACTH and
glucocorticoids, have a depressing effect on D5- and
6 w xD -desaturase activities 42,43 and some others, as
GH and thyroid hormone, have an enhancing effect
on these activities, as demonstrated by our results. In
the case of the D5-desaturase activity, the effect of
the enhancing hormones seems to be the most impor-
tant, since the overall effect of hypophysectomy in-
duces a marked decrease in this activity. In the case
of the D6-desaturase activity, the respective effects of
depressive and enhancing hormones seem to be more
balanced since no overall effect of hypophysectomy
can be shown in this study.
Finally, the regulation of fatty acid composition of
microsomal membrane involves, besides dietary fac-
tors, several hormonal systems which are overlapped
and not additive. GH and thyroid hormones play an
important role in this regulation. The exact mecha-
nism by which GH modifies the desaturationrelonga-
tion systems and consequently the fatty acid composi-
tion of microsomal membrane is still unknown.
w x w xTherefore, Waxman et al. 44 and Ram et al. 45
have very recently shown that intermittent GH pulsa-
 .tion male GH secretion pattern could trigger tyro-
sine phosphorylation and the nuclear translocation of
a liver-expressed DNA-binding protein. Such a nu-
clear regulation factor could be invoked for the tran-
scription regulation of the genes of these desatura-
tionrelongation systems. The fact that GH treatment
can ‘feminize’ the hepatic fatty acid composition of
microsomal membrane via the modulation of the
desaturationrelongation activities, as it ‘feminizes’
the hepatic steroid metabolism, could indicate that the
secretion pattern of GH is implicated in the regula-
tion of these desaturationrelongation activities.
In conclusion, the ‘feminization’ process of the
microsomal fatty acid composition in male rats treated
with GH only slightly affects overall unsaturation in
fatty acids, but it increases their carbon chain length.
The consequences of such global modifications on
the structure and the functions of microsomal mem-
brane, particularly on some membrane-bound en-
zymes and on membrane-bound receptors or molecule
carriers, which are known to depend on environmen-
tal factors, such as membrane integrity and fluidity
w x46 , remain to be established. The modifications in
the proportion of special fatty acids, such as 20:4ny
6, which is the precursor of numerous compounds of
biological importance such as eicosanoids and of
reactive lipoperoxidation products, such as 4-hy-
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droxynonenal, could also have important conse-
quences that have to be determined.
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